Journal Article

A possible beneficial effect of Bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases

Sasaki, Kengo, Tabata, Tokiko, Saito, Yoshihiro, Takahashi, Tomoya, Kishino, Shigenobu, Kondo, Akihiko, Yoshida, Naofumi, Osawa, Ro, Yamada, Takuji, Sugiyama, Yuta, Yamashita, Tomoya, Hayashi, Tomohiro, Shinohara, Masakazu, Kitamura, Nahoko, Hirata, Ken-ichi, Ogawa, Jun, Sasaki, Daisuke, Emoto, Takuo, Watanabe, Hikaru

2020

Overview

Faecal lipopolysaccharides (LPS) have attracted attention as potent elements to explain a correlation between the gut microbiota and cardiovascular disease (CVD) progression. However, the underlying mechanism of how specific gut bacteria contribute to faecal LPS levels remains unclear. We retrospectively analysed the data of 92 patients and found that the abundance of the genus Bacteroides was significantly and negatively correlated with faecal LPS levels. The controls showed a higher abundance of Bacteroides than that in the patients with CVD. The endotoxin units of the Bacteroides LPS, as determined by the limulus amoebocyte lysate (LAL) tests, were drastically lower than those of the Escherichia coli LPS; similarly, the Bacteroides LPS induced relatively low levels of pro-inflammatory cytokine production and did not induce sepsis in mice. Fermenting patient faecal samples in a single-batch fermentation system with Bacteroides probiotics led to a significant increase in the Bacteroides abundance, suggesting that the human gut microbiota could be manipulated toward decreasing the faecal LPS levels. In the clinical perspective, Bacteroides decrease faecal LPS levels because of their reduced LAL activity; therefore, increasing Bacteroides abundance might serve as a novel therapeutic approach to prevent CVD via reducing faecal LPS levels and suppressing immune responses.

• Publisher: Nature Publishing Group UK,Nature Publishing Group
• Subject: 631/250 / 631/326 / 692/4019 / Abundance / Aged / Animals / Bacteroides / Bacteroides - genetics / Bacteroides - metabolism / Cardiovascular diseases / Cardiovascular Diseases - metabolism / Cardiovascular Diseases - microbiology / Case-Control Studies / E coli / Endotoxins / Feces / Feces - chemistry / Feces - microbiology / Female / Fermentation / Gastrointestinal Microbiome / Humanities and Social Sciences / Humans / Immune response / Inflammation / Intestinal microflora / Lipopolysaccharides / Lipopolysaccharides - metabolism / Male / Mice / Mice, Inbred C57BL / Microbiota / Middle Aged / multidisciplinary / Probiotics / RAW 264.7 Cells / Retrospective Studies / RNA, Ribosomal, 16S - genetics / Science / Science (multidisciplinary) / Sepsis